Scale by Design - Venture Capital Show
Scale by Design - Venture Capital Show
✓

EP 16: Capacity planning, conversion rates & when it makes sense to hire externally w Jen Spencer

00:40:11
Podcasts
RSS
Link

OM DENNE EPISODE

Jen Spencer, CEO at SmartBug Media joins host James Mackey on the Scale by Design show to discuss capacity planning, capacity utilization, when it makes sense to scale existing staff versus when it makes sense to hire externally, how you keep great people engaged & more!

https://www.linkedin.com/in/jenspencer/

Our host James Mackey, SecureVision CEO

Listen to our full episode list here:
https://www.scalebydesign.io/

Follow us:
https://www.linkedin.com/company/scalebydesign/

Our YouTube channel:
https://www.youtube.com/@securevision1677

#1 Rated Embedded Recruitment Firm on G2!
https://www.g2.com/products/securevision/reviews

Thanks for listening!

Marketing
Forretning
Iværksætteri
Investering
Engelsk
USA
BrugAPItil at hente denne episode iJSON

I DENNE EPISODE

Redigér disse tags

UDSKRIFT 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SØG BLANDT TIDLIGERE EPISODER

Søg efter gamle afsnit af Scale by Design - Venture Capital Show.
Integrer denne søgefelt på dit websted

ANDRE EPISODE I DENNE PODCAST

S2 E8: How to make the career transition into VC. The vast range of opportunity in ClimateTech w David J. Neff

S2 E8: How to make the career transition into VC. The vast range of opportunity in ClimateTech w David J. Neff

David J. Neff, Partner at Ecliptic Capital, shares his experience breaking into the VC industry. He discusses the value add of non-traditional backgrounds in VC. And breaks down the enormous range of opportunities in ClimateTech. Our host James Mackey, SecureVision CEOListen to our full episode li…
00:35:02
DEL
GEM
S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber

S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber

Jason Webber, Principal and Co-Founder at Sustainable Conversion Ventures joins host James Mackey on Scale by Design - Venture Capital Show.Jason Webber explains how many great innovations will die on the vine with the growing shortfall of semi-commercial fermentation capacity. Not necessarily capa…
00:54:10
DEL
GEM
S2 E7: The value propositions of an operator-led fund. Tapping into the power of the LP community w Scott Barker, GTMfund Co-founder

S2 E7: The value propositions of an operator-led fund. Tapping into the power of the LP community w Scott Barker, GTMfund Co-founder

Scott shares his founding story of GTMfund and the power of having an operator-led fund. He breaks down how every stage of the VC lifecycle is optimized at GTMfund and how this has contributed to almost all of their investments raising subsequent funds.  Our host James Mackey, SecureVision CEOLis…
00:41:07
DEL
GEM
S2 E6: Next-gen commerce and how to uncover investment opportunities that most investors miss w Michael Nogen

S2 E6: Next-gen commerce and how to uncover investment opportunities that most investors miss w Michael Nogen

Michael Nogen, the Managing Partner of Overton Venture Capital, shares his thoughts on next-gen commerce, his investment philosophy, and how VCs and founders need to approach 2023.  Our host James Mackey, SecureVision CEOListen to our full episode list here:https://www.scalebydesign.io/Follow us:…
00:41:18
DEL
GEM
S2 E5: Why pharma startups need to innovate the drug development process. The importance of a patient first approach w Leen Kawas

S2 E5: Why pharma startups need to innovate the drug development process. The importance of a patient first approach w Leen Kawas

Leen Kawas, the Managing General Partner of Propel Bio Partners, shares how her unique background as a pharmacist, entrepreneur, scientist, and investor has influenced her perspective on startups and the drug development lifecycle.  Our host James Mackey, SecureVision CEOListen to our full episod…
00:47:25
DEL
GEM
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra SecureVision, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.
PROMOTED
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

ANBEFALINGER
Brug API til at hente denne episode